Skip to main content
Helmholtz Munich | ©UNRAU FOTOGRAFIE

For a Healthier Society: HI-MAG Celebrates 5th Anniversary

Awards & Grants, HI-MAG, Pioneer Campus,

Investigating Metabolic, Obesity and Vascular Diseases


The Helmholtz Institute for Metabolic, Obesity and Vascular Research (Helmholtz-Institut für Metabolismus-, Adipositas- und Gefäßforschung, HI-MAG), an institute from Helmholtz Munich at the University of Leipzig and the University of Leipzig Medical Center, held a symposium to celebrate its 5th anniversary. A large number of guests participated in the event to collectively celebrate previous achievements in the field of health research related to obesity, metabolic, and vascular diseases.


Metabolic disorders such as diabetes and obesity have been on the rise in recent decades, increasing the risk of vascular diseases for patients. Furthermore, these diseases can significantly impair the quality of life and life expectancy of those affected. These so-called "lifestyle diseases" are among the greatest challenges of our time for our society and health. The Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) addresses precisely these challenges. Helmholtz Munich established the institute five years ago in collaboration with the Medical Faculty of the University of Leipzig and the University of Leipzig Medical Center. HI-MAG brings together scientists from basic and clinical research to further develop new approaches for the treatment of obesity, metabolic, and vascular diseases and to facilitate access for patients.

With guests from politics and science, HI-MAG celebrated its 5th anniversary on June 12, 2023, in Leipzig with a symposium. More than 80 invited guests received insights about achievements during the institute's initial years and about future goals from the staff working at HI-MAG. Since its establishment, researchers at the institute have, for instance, identified a new risk gene for childhood obesity, and elucidated mechanisms for the impairment of organ health in the liver, adipose tissue, and vessels caused by a poor diet. Additionally, state-of-the-art medications for the treatment of obesity and type-2 diabetes, developed in part through the basic research at Helmholtz Munich, are currently being tested in clinical trials, to name just a few of the outstanding accomplishments.

Despite the spatial separation between Leipzig and Munich, the collaboration could not be closer. HI-MAG serves as the link between basic research at Helmholtz Munich and clinical application at the University of Leipzig Medical Center, enabling the rapid transfer of the latest findings to the patient. Following the symposium, HI-MAG opened its doors to the guests, providing a more detailed insight into the institute’s current clinical and translational projects through its own study clinic and laboratories, and facilitating conversations with the HI-MAG scientists.


More information

Read the full press release in German here 

Find out more about the Bioengeenering cooperation between Helmholtz Munich and the University of Leipzig at the Helmholtz Pioneer Campus here 

Check out some outstanding research results from HI-MAG: 

Obesity researchers discover new gene mutation in children

What does poor diet do to our blood vessels?